ArticleNature communications2026

MicroRNA-30c analog C2 decreases plasma cholesterol and atherosclerosis without causing liver injury in preclinical studies.

Binu Prakash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.